Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

Laurence L. Greenhill; Doris H. Beyer; Jami Finkleson; David Shaffer; Joseph Biederman; C. Keith Conners; Christopher Gillberg; Michael Huss; Peter Jensen; James L. Kennedy; Rachel Klein; Judith Rapoport; Terje Sagvolden; Tom Spencer; James M. Swanson; Nora Volkow

doi:10.1177/070674370200601s11

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

Laurence L. Greenhill, Doris H. Beyer, Jami Finkleson, David Shaffer, Joseph Biederman, C. Keith Conners, Christopher Gillberg, Michael Huss, Peter Jensen, James L. Kennedy, Rachel Klein, Judith Rapoport, Terje Sagvolden, Tom Spencer, James M. Swanson, Nora Volkow

Research output: Contribution to journal › Review article › peer-review

73 Scopus citations

Abstract

Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

Original language	English
Pages (from-to)	S-89-S-100
Journal	Journal of Attention Disorders
Volume	6
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1177/070674370200601s11
State	Published - 2002
Externally published	Yes

Access to Document

10.1177/070674370200601s11

Cite this

Greenhill, L. L., Beyer, D. H., Finkleson, J., Shaffer, D., Biederman, J., Conners, C. K., Gillberg, C., Huss, M., Jensen, P., Kennedy, J. L., Klein, R., Rapoport, J., Sagvolden, T., Spencer, T., Swanson, J. M., & Volkow, N. (2002). Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Journal of Attention Disorders, 6(SUPPL. 1), S-89-S-100. https://doi.org/10.1177/070674370200601s11

@article{dc0b2feff6b1465c9463bcab134a3f9a,

title = "Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder",

abstract = "Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.",

author = "Greenhill, {Laurence L.} and Beyer, {Doris H.} and Jami Finkleson and David Shaffer and Joseph Biederman and Conners, {C. Keith} and Christopher Gillberg and Michael Huss and Peter Jensen and Kennedy, {James L.} and Rachel Klein and Judith Rapoport and Terje Sagvolden and Tom Spencer and Swanson, {James M.} and Nora Volkow",

year = "2002",

doi = "10.1177/070674370200601s11",

language = "English",

volume = "6",

pages = "S--89--S--100",

journal = "Journal of Attention Disorders",

issn = "1087-0547",

publisher = "SAGE Publications Inc.",

number = "SUPPL. 1",

}

Greenhill, LL, Beyer, DH, Finkleson, J, Shaffer, D, Biederman, J, Conners, CK, Gillberg, C, Huss, M, Jensen, P, Kennedy, JL, Klein, R, Rapoport, J, Sagvolden, T, Spencer, T, Swanson, JM & Volkow, N 2002, 'Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder', Journal of Attention Disorders, vol. 6, no. SUPPL. 1, pp. S-89-S-100. https://doi.org/10.1177/070674370200601s11

TY - JOUR

T1 - Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

AU - Greenhill, Laurence L.

AU - Beyer, Doris H.

AU - Finkleson, Jami

AU - Shaffer, David

AU - Biederman, Joseph

AU - Conners, C. Keith

AU - Gillberg, Christopher

AU - Huss, Michael

AU - Jensen, Peter

AU - Kennedy, James L.

AU - Klein, Rachel

AU - Rapoport, Judith

AU - Sagvolden, Terje

AU - Spencer, Tom

AU - Swanson, James M.

AU - Volkow, Nora

PY - 2002

Y1 - 2002

N2 - Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

AB - Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.

UR - http://www.scopus.com/inward/record.url?scp=1642399677&partnerID=8YFLogxK

U2 - 10.1177/070674370200601s11

DO - 10.1177/070674370200601s11

M3 - Review article

C2 - 12685523

AN - SCOPUS:1642399677

SN - 1087-0547

VL - 6

SP - S-89-S-100

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

IS - SUPPL. 1

ER -

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder

Abstract

Access to Document

Fingerprint

Cite this